Beyond “pay-for-delay” – the EU-Commission’s investigation into patent filing practices and communication measures

Published date27 April 2021
Subject MatterPatents,Pay-For-Delay,European Commission,EU,Generic Drugs,Anti-Competitive,Pharmaceutical Patents,European Patent Office,Settlement Agreements,Patent Validity,Pharmaceutical Industry
AuthorDr. Lukas Rengier
Law FirmAllen & Overy LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT